home / stock / aezs:cc / aezs:cc news


AEZS:CC News and Press, Aeterna Zentaris Inc.

Stock Information

Company Name: Aeterna Zentaris Inc.
Stock Symbol: AEZS:CC
Market: TSXC
Website: zentaris.com

Menu

AEZS:CC AEZS:CC Quote AEZS:CC Short AEZS:CC News AEZS:CC Articles AEZS:CC Message Board
Get AEZS:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

AEZS:CC - Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders

TORONTO, ONTARIO, July 16, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for he...

AEZS:CC - Canadian Companies Moving the Markets, Morning edition
Fri, Jun 21, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada Cenovus Energy Inc. (CVE) fell 0.4% to $25.64 on volume of 35,553,128 shares TC Energy Corporation (TRP) fell 0.1% to $52.18 on volume of 18,009,642 shares Imperial Oil Limited (IMO) fell 1.4% to $89.8 on volume of 13,207,055 shares Power Corp...

AEZS:CC - Canadian Companies Moving the Markets, Evening edition
Thu, Jun 20, 2024 as of 4:00 pm ET

A look at the top 10 most actives in Canada Calibre Mining Corp. (CXB) fell 1.6% to $1.86 on volume of 86,371,011 shares Canadian Natural Resources Limited (CNQ) rose 1.4% to $47.88 on volume of 49,807,484 shares TC Energy Corporation (TRP) fell 0.1% to $52.22 on volume of 16,162,139 shar...

AEZS:CC - Canadian Companies Moving the Markets, Morning edition
Thu, Jun 20, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada Calibre Mining Corp. (CXB) fell 2.9% to $1.835 on volume of 79,684,444 shares Canadian Natural Resources Limited (CNQ) rose 1.6% to $48 on volume of 6,456,525 shares Alaris Equity Partners Income Trust 5.50% convertible unsecured subordinated de...

AEZS:CC - Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

Company expects to report top-line data and complete study results in Q3 2024 TORONTO, ONTARIO, June 13, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing a...

AEZS:CC - Aeterna Zentaris and Ceapro Complete Merger Transaction

TORONTO and EDMONTON, Alberta, June 03, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”) and Ceapro Inc. (TSX-V: CZO) (OTCQX: CRPOF) (“Ceapro”), two innovative biopharmaceutical development companies, ...

AEZS:CC - Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date

TORONTO, ONTARIO, May 29, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, t...

AEZS:CC - Aeterna Zentaris Announces Details Regarding Transaction with Ceapro

TORONTO, ON, May 17, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ” or the “ Company ”) announces that it has finalized certain details regarding the previously announced merger of equals transaction (the “ Tra...

AEZS:CC - Aeterna Zentaris Reports First Quarter 2024 Financial Results

Company ended the quarter with $29.5 million in cash DETECT-trial recruitment completed; Company continues to expect the completion of the trial in the second quarter and top-line data in the third quarter of 2024 All-stock merger of equals transaction with Ceapro Inc. exp...

AEZS:CC - Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (" Aeterna ") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approvin...

Next 10